X-139530815-C-T
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_000133.4(F9):c.51C>T(p.Ile17=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000128 in 1,209,372 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 39 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., 5 hem., cov: 24)
Exomes 𝑓: 0.00013 ( 0 hom. 34 hem. )
Consequence
F9
NM_000133.4 synonymous
NM_000133.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.121
Genes affected
F9 (HGNC:3551): (coagulation factor IX) This gene encodes vitamin K-dependent coagulation factor IX that circulates in the blood as an inactive zymogen. This factor is converted to an active form by factor XIa, which excises the activation peptide and thus generates a heavy chain and a light chain held together by one or more disulfide bonds. The role of this activated factor IX in the blood coagulation cascade is to activate factor X to its active form through interactions with Ca+2 ions, membrane phospholipids, and factor VIII. Alterations of this gene, including point mutations, insertions and deletions, cause factor IX deficiency, which is a recessive X-linked disorder, also called hemophilia B or Christmas disease. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
?
Variant X-139530815-C-T is Benign according to our data. Variant chrX-139530815-C-T is described in ClinVar as [Benign]. Clinvar id is 697610.Status of the report is reviewed_by_expert_panel, 3 stars.
BP7
?
Synonymous conserved (PhyloP=0.121 with no splicing effect.
BS1
?
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.00013 (143/1096890) while in subpopulation AMR AF= 0.00389 (137/35192). AF 95% confidence interval is 0.00336. There are 0 homozygotes in gnomad4_exome. There are 34 alleles in male gnomad4_exome subpopulation. Median coverage is 29. This position pass quality control queck.
BS2
?
High Hemizygotes in GnomAd at 5 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
F9 | NM_000133.4 | c.51C>T | p.Ile17= | synonymous_variant | 1/8 | ENST00000218099.7 | |
F9 | NM_001313913.2 | c.51C>T | p.Ile17= | synonymous_variant | 1/7 | ||
F9 | XM_005262397.5 | c.51C>T | p.Ile17= | synonymous_variant | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
F9 | ENST00000218099.7 | c.51C>T | p.Ile17= | synonymous_variant | 1/8 | 1 | NM_000133.4 | P1 | |
F9 | ENST00000394090.2 | c.51C>T | p.Ile17= | synonymous_variant | 1/7 | 1 | |||
F9 | ENST00000479617.2 | n.58C>T | non_coding_transcript_exon_variant | 1/4 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.000107 AC: 12AN: 112482Hom.: 0 Cov.: 24 AF XY: 0.000144 AC XY: 5AN XY: 34650
GnomAD3 genomes
?
AF:
AC:
12
AN:
112482
Hom.:
Cov.:
24
AF XY:
AC XY:
5
AN XY:
34650
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000677 AC: 124AN: 183099Hom.: 0 AF XY: 0.000443 AC XY: 30AN XY: 67691
GnomAD3 exomes
AF:
AC:
124
AN:
183099
Hom.:
AF XY:
AC XY:
30
AN XY:
67691
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000130 AC: 143AN: 1096890Hom.: 0 Cov.: 29 AF XY: 0.0000938 AC XY: 34AN XY: 362368
GnomAD4 exome
AF:
AC:
143
AN:
1096890
Hom.:
Cov.:
29
AF XY:
AC XY:
34
AN XY:
362368
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.000107 AC: 12AN: 112482Hom.: 0 Cov.: 24 AF XY: 0.000144 AC XY: 5AN XY: 34650
GnomAD4 genome
?
AF:
AC:
12
AN:
112482
Hom.:
Cov.:
24
AF XY:
AC XY:
5
AN XY:
34650
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: reviewed by expert panel
LINK: link
Submissions by phenotype
Hereditary factor IX deficiency disease Benign:2
Benign, reviewed by expert panel | curation | ClinGen Coagulation Factor Deficiency Variant Curation Expert Panel, Clingen | Feb 09, 2024 | The NM_000133.4:c.51C>T (p.Ile17=) synonymous variant is reported at a high MAF of 0.004462 (125/28017 alleles with 31 hemizygotes) in the Latino population of gnomAD v2.1.1, meeting the BA1 cut-off of >/= 0.0000556. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: BA1. - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 11, 2020 | - - |
Hereditary factor IX deficiency disease;C2749016:Thrombophilia, X-linked, due to factor 9 defect Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 27, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at